GeneFerm Biotechnology Co., Ltd. (1796)
Market Closed
11 Aug, 05:30
TWSE 
HKEX Primary TWSE NT$
30. 75
+0.05
+0.1629%
NT$
- Market Cap
- P/E Ratio
0.32% Div Yield
19,000 Volume
- Eps
NT$ 30.7
Previous Close Want to track 1796 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
GeneFerm Biotechnology Co., Ltd. (1796) Statistics
Valuation metrics
Market Cap -
Enterprise value 1.32B
Trailing P/E (ttm) 80.92
Forward P/E -
PEG ratio 0.02
Price/Sales (ttm) 1.92
Price/Book (mrq) 1.63
Enterprise Value/Revenue 1.98
Enterprise Value/EBITDA 13.52
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 27.8K
Average volume (90 days) 25.47K
Price summary
52-Week low 28.25
52-Week high 67.1
Beta -
50-Day moving average 32.1
200-Day moving average 37.32
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.7
Trailing annual dividend yield 0.0228%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 30 Jul 2026
Ex-Dividend Date 14 Jul 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.02%
Operating margin 0.05%
Operational effectiveness
Return on assets 0.01%
Return on equity 0.02%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 16.01
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.38
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.73
Total debt (mrq) -
Total Debt/Equity (mrq) 0.41
Current ratio (mrq) 3.24%
Book value per share (mrq) 18.85
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
